Esen Akpek is an Ophthalmology physician affiliated with Johns Hopkins University. OpenAlex indexes 278 publications with 13,097 citations (h-index 57); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-5080Registry record last updated 6 Apr 2015.
Clinical trials
- Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
Sponsor: Johns Hopkins University
- Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
Sponsor: Johns Hopkins University
- Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- W. L. Gore & Associates, Inc.Program year2025110 payments$353,714openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year20252 payments$15,000openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year20255 payments$12,422openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
31.4%Antibiotics31.4%Bacitracin-Polymyxin100%Part D≥45 patientsAnti-infectives
28.4%Macrolide Antimicrobial11.3%Azithromycin100%Part D≥19 patientsMacrolide10.3%Erythromycin100%Part D<11 patients+ 1 more class in this area
Sensory organs
27.8%Corticosteroid13.9%Prednisolone Acetate100%Part D≥18 patientsCorticosteroids, plain8.2%Difluprednate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2023 International Rome consensus for the nomenclature of Sjögren disease
Nature Reviews Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”